The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Hospira Inc

NYSE: HSP
Last

(U.S.) $60.29

Today's change0.00 0.00%
Updated November 26 4:07 PM EST. Delayed by at least 15 minutes.
 

Hospira Inc

NYSE: HSP
Last

(U.S.) $60.29

Today's change0.00 0.00%
Updated November 26 4:07 PM EST. Delayed by at least 15 minutes.

Hospira Inc closed at (U.S.)$60.29.

Over the last five days, shares have gained 2.52% and 46.05% year to date. Shares have outperformed the S&P 500 by 39.26% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $60.29
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+46.05%
  • Volume0
  • Average volume (10-day)944,737
  • Average volume (1-month)1,054,267
  • Average volume (3-month)924,858
  • 52-week range(U.S.) $39.05 to (U.S.) $60.78
  • Beta0.56
  • Trailing P/E30.99×
  • P/E 1 year forward24.46×
  • Forward PEG2.07×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.95
Updated November 26 4:07 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.05%

Based on its net profit margin of 7.05%, Hospira Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.77%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,1511,1361,0511,084
Total other revenue--------
Total revenue1,1511,1361,0511,084
Gross profit444426383364
Total cost of revenue707710668720
Total operating expense9231,0369511,031
Selling / general / administrative224211186187
Research & development86768384
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-94401441
Other operating expenses, total--------
Operating income22810010053
Interest income (expense), net non-operating-19-19-21-23
Gain (loss) on sale of assets--------
Other--------
Income before tax204818128
Income after tax155626530
Income tax, total491917-2
Net income159716834
Total adjustments to net income--------
Net income before extra. items159716834
Minority interest--------
Equity in affiliates3934
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items159716834
Inc. avail. to common incl. extra. items159716834
Diluted net income159716834
Dilution adjustment0----0
Diluted weighted average shares172170168166
Diluted EPS excluding extraordinary itemsvalue per share0.920.420.400.20
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.510.600.470.36